124 related articles for article (PubMed ID: 2886054)
1. Corelease of PHI and VIP by vagal stimulation in the dog.
Yasui A; Naruse S; Yanaihara C; Ozaki T; Hoshino M; Mochizuki T; Daniel EE; Yanaihara N
Am J Physiol; 1987 Jul; 253(1 Pt 1):G13-9. PubMed ID: 2886054
[TBL] [Abstract][Full Text] [Related]
2. Co-release of PHI and VIP in dog stomach by peripheral and central vagal stimulation.
Ohta T; Ito S; Ohga A
Br J Pharmacol; 1990 Jun; 100(2):231-6. PubMed ID: 2379030
[TBL] [Abstract][Full Text] [Related]
3. Vagal-induced tachycardia: release of vasoactive intestinal peptide and peptide HI.
Anderson FL; Kralios AC; Cluff N; Hanson GR
Am J Physiol; 1994 Nov; 267(5 Pt 2):H2019-24. PubMed ID: 7977833
[TBL] [Abstract][Full Text] [Related]
4. Regulatory mechanisms in the luminal and portal release of vasoactive intestinal polypeptide during vagal nerve stimulation in the cat.
Blank MA; Kimura K; Jaffe BM
Regul Pept; 1988 Oct; 23(1):15-26. PubMed ID: 2907169
[TBL] [Abstract][Full Text] [Related]
5. Gastric vasodilatation and vasoactive intestinal peptide output in response to vagal stimulation in the dog.
Ito S; Ohga A; Ohta T
J Physiol; 1988 Oct; 404():669-82. PubMed ID: 2908127
[TBL] [Abstract][Full Text] [Related]
6. Effects of acute and long-term atropine treatment on levels, release and response to VIP and PHI in the submandibular gland of cat and rat.
Dunér-Engström M; Larsson O; Fredholm BB; Lundblad L; Fahrenkrug J; Lundberg JM
Acta Physiol Scand; 1992 Nov; 146(3):357-67. PubMed ID: 1336298
[TBL] [Abstract][Full Text] [Related]
7. Effects of hexamethonium and atropine on the basal levels of immunoreactive vasoactive intestinal polypeptide in dogs.
Misawa T; Chijiiwa Y; Ibayashi H
Gastroenterol Jpn; 1986 Dec; 21(6):579-83. PubMed ID: 2883064
[TBL] [Abstract][Full Text] [Related]
8. Vagal release of IR-VIP and IR-gastrin from the isolated perfused rat stomach.
Pederson R; O'Dorisio T; Howe B; McIntosh C; Mueller M; Brown J; Cataland S
Mol Cell Endocrinol; 1981 Aug; 23(2):225-31. PubMed ID: 7274550
[TBL] [Abstract][Full Text] [Related]
9. Corelease of vasoactive intestinal polypeptide and peptide histidine isoleucine in relation to atropine-resistant vasodilation in cat submandibular salivary gland.
Lundberg JM; Fahrenkrug J; Larsson O; Anggård A
Neurosci Lett; 1984 Nov; 52(1-2):37-42. PubMed ID: 6098877
[TBL] [Abstract][Full Text] [Related]
10. VIP and PHI in the pig pancreas: coexistence, corelease, and cooperative effects.
Holst JJ; Fahrenkrug J; Knuhtsen S; Jensen SL; Nielsen OV; Lundberg JM; Hökfelt T
Am J Physiol; 1987 Feb; 252(2 Pt 1):G182-9. PubMed ID: 3548423
[TBL] [Abstract][Full Text] [Related]
11. Vagal control of nitric oxide and vasoactive intestinal polypeptide release in the regulation of gastric relaxation in rat.
Takahashi T; Owyang C
J Physiol; 1995 Apr; 484 ( Pt 2)(Pt 2):481-92. PubMed ID: 7602539
[TBL] [Abstract][Full Text] [Related]
12. Concentrations and distribution of vasoactive intestinal peptide (VIP), peptide histidine isoleucine (PHI) and peptide histidine valine (PHV) in the cerebral cortex and the suprachiasmatic nucleus of the mouse.
Mikkelsen JD; Fahrenkrug J
Brain Res; 1994 Sep; 656(1):95-107. PubMed ID: 7804850
[TBL] [Abstract][Full Text] [Related]
13. Is peptide histidine isoleucine an inhibitory nonadrenergic noncholinergic neurotransmitter in the rat gastric fundus?
D'Amato M; Currò D; Ciabattoni G; Lefebvre RA
Arch Int Pharmacodyn Ther; 1990; 303():216-31. PubMed ID: 1973609
[TBL] [Abstract][Full Text] [Related]
14. The vagal control of the pyloric motor function: a physiological and immunohistochemical study in cat and man.
Edin R
Acta Physiol Scand Suppl; 1980; 485():1-30. PubMed ID: 6163319
[TBL] [Abstract][Full Text] [Related]
15. Release of vasoactive intestinal polypeptide (VIP) by electric stimulation of the vagal nerves.
Schaffalitzky de Muckadell OB; Fahrenkrug J; Holst JJ
Gastroenterology; 1977 Feb; 72(2):373-5. PubMed ID: 830595
[TBL] [Abstract][Full Text] [Related]
16. VIP and noncholinergic vasodilatation in rabbit submandibular gland.
Fazekas A; Gazelius B; Edwall B; Theodorsson-Norheim E; Blomquist L; Lundberg JM
Peptides; 1987; 8(1):13-20. PubMed ID: 2437546
[TBL] [Abstract][Full Text] [Related]
17. Molecular forms of peptide histidine isoleucine-like immunoreactivity in the gastrointestinal tract. Nonequimolar levels of peptide histidine isoleucine and vasoactive intestinal peptide in the stomach explained by the presence of a big peptide histidine isoleucine-like molecule.
Yiangou Y; Christofides ND; Blank MA; Yanaihara N; Tatemoto K; Bishop AE; Polak JM; Bloom SR
Gastroenterology; 1985 Sep; 89(3):516-24. PubMed ID: 3839480
[TBL] [Abstract][Full Text] [Related]
18. Gastric relaxation and vasoactive intestinal peptide output in response to reflex vagal stimulation in the dog.
Ito S; Ohga A; Ohta T
J Physiol; 1988 Oct; 404():683-93. PubMed ID: 3253446
[TBL] [Abstract][Full Text] [Related]
19. Effect and mechanism of vagal nerve stimulation on somatostatin secretion in dogs.
Ahrén B; Paquette TL; Taborsky GJ
Am J Physiol; 1986 Feb; 250(2 Pt 1):E212-7. PubMed ID: 2869692
[TBL] [Abstract][Full Text] [Related]
20. Release of immunoreactive vasoactive intestinal peptide (VIP) from the gallbladder in response to vagal stimulation.
Björck S; Fahrenkrug J; Jivegård L; Svanvik J
Acta Physiol Scand; 1986 Dec; 128(4):639-42. PubMed ID: 3811988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
